Advertisement

Molecular Neurobiology

, Volume 54, Issue 2, pp 1173–1186 | Cite as

Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis

  • Vandana RaiEmail author
Article

Abstract

Methylenetetrahydrofolate reductase (MTHFR) is key enzyme of folate/homocysteine pathway. Case control association studies on MTHFR C677T polymorphism and Alzheimer’s disease (AD) have been repeatedly performed over the last two decades, but the results are inconclusive. The aim of the present study was to assess the risk of MTHFR C677T polymorphism for AD. Forty-one studies were identified by a search of PubMed, Google Scholar, Elsevier, and Springer Link databases, up to January 2015. Odds ratios (ORs) with corresponding 95 % confidence interval (CI) were calculated using fixed effect model or random effect model. The subgroup analyses based on ethnicity were performed. MTHFR C677T polymorphism had a significant association with susceptibility to AD in all genetic models (for T vs C OR = 1.29, 95 % CI = 1.07–1.56, p = 0.003; for TT + CT vs CC OR = 1.29, 95 % CI = 1.19–1.40, p = 0.0004; for TT vs CC OR = 1.31, 95 % CI = 1.16–1.48, p = 0.001; for CT vs CC OR = 1.24, 95 % CI = 1.13–1.35, p < 0.004; and for TT vs CT + CC OR = 1.13, 95 % CI = 1.00–1.28, p = 0.02). Results of present meta-analysis supported that the MTHFR C677T polymorphism was associated with an increased risk of AD.

Keywords

Alzheimer’s disease MTHFR C677T Neurodegeneration Homocysteine Folate 

Notes

Acknowledgments

The authoress is highly grateful to Leon Bax (Chief Scientific Officer at BiostatXL, UMC Utrecht) for his valuable suggestions, which help me in statistical analysis.

References

  1. 1.
    Luchsinger J, Mayeux R (2004) Cardiovascular risk factors and Alzheimer’s diseases. Curr Atheroscler Rep 6:261–266CrossRefPubMedGoogle Scholar
  2. 2.
    Wingo TS, Lah JJ, Levey AI, Cutler DJ (2012) Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol 69:59–64CrossRefPubMedGoogle Scholar
  3. 3.
    Prince DL, Sisodia SS, Borchett DR (1998) Alzheimer disease: when or why? Nat Genet 19:314–316CrossRefGoogle Scholar
  4. 4.
    Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, Levesque G, Rogaev EI et al (1996) Fifteen-year longitudinal study of blood pressure and dementia. Lancet 347:1141–1145CrossRefGoogle Scholar
  5. 5.
    Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483CrossRefPubMedGoogle Scholar
  6. 6.
    Ott A, Stolk RP, van Harskamp F et al (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53:1937–1942CrossRefPubMedGoogle Scholar
  7. 7.
    Jick H, Zornberg GL, Jick SS et al (2000) Statins and the risk of dementia. Lancet 356:1627–1631CrossRefPubMedGoogle Scholar
  8. 8.
    Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80:114–122PubMedGoogle Scholar
  9. 9.
    Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129–132PubMedGoogle Scholar
  10. 10.
    Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V (2015) Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab Brain Dis 9:25005003Google Scholar
  11. 11.
    Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113CrossRefPubMedGoogle Scholar
  12. 12.
    Yamada K, Zhoutao C, Rima R, Mathews RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 98:14853–14858CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Rozen R (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methelenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523–526PubMedGoogle Scholar
  14. 14.
    Pepe G, Venegas OC, Giusti B, Brunelli T, Marcucci R, Attanasio M et al (1998) Heterogeneity in world distribution of thermolabile C677T mutation in 5, 10-methylenetetrahydrofolate reductase. Am J Hum Genet 63:917–920CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Schneider JA, Rees DC, Liu YT, Clegg JB (1998) World distribution of a common methylenetetrahydrofalate reductase mutation. Am J Hum Gene 62:1258–1260CrossRefGoogle Scholar
  16. 16.
    Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M et al (2003) Geographical and ethnic variation of the 677C > T allele of 5,10-methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet 40:619–625CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Spiridonova MG, Stepanov VA, Maksimova NR, Puzyrev VP (2004) Population study of frequency of methylenetetrahydrofolate reductase C677T gene polymorphism in Yakutia. Genetika 40:704–708PubMedGoogle Scholar
  18. 18.
    Rai V, Yadav U, Kumar P (2012) Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh. Indian J Human Genetics 18:43–46CrossRefGoogle Scholar
  19. 19.
    Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H et al (2003) Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101:2483–2488CrossRefPubMedGoogle Scholar
  20. 20.
    Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH (2006) Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am J Clin Nutr 83:708–713PubMedGoogle Scholar
  21. 21.
    Chapman J, Wang N, Treves A, Korczyn AD, Bornstein NM (1998) ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer’s dementia. Stroke 29:1401–1404CrossRefPubMedGoogle Scholar
  22. 22.
    Brunelli T, Bagnoli S, Giusti B, Nacmias B, Pepe G, Sorbi S, Abbate R (2001) The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer’s disease. Neurosci Lett 315:103–105CrossRefPubMedGoogle Scholar
  23. 23.
    Zuliani G, Ble A, Zanca R, Munari MR, Zurlo A, Vavalle C, Atti AR, Fellin R (2001) Genetic polymorphisms in older subjects with vascular or Alzheimer’s dementia. Acta Neurol Scand 103:304–308CrossRefPubMedGoogle Scholar
  24. 24.
    Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B et al (2003) Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer’s disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16:64–70CrossRefPubMedGoogle Scholar
  25. 25.
    Seripa D, Forno GD, Matera MG, Gravina C, Margaglione M, Palermo MT, Wekstein DR, Antuono P et al (2003) Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol Aging 24:933–939CrossRefPubMedGoogle Scholar
  26. 26.
    Linnebank M, Linnebank A, Jeub M, Klockgether T, Wullne U, Kolsch H, Heun R, Koch HG et al (2004) Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am J Med Genet A 131:101–102CrossRefPubMedGoogle Scholar
  27. 27.
    Wang B, Jin F, Kan R, Ji S, Zhang C, Lu Z, Zheng C, Yang Z et al (2005) Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer’s disease. J Mol Neurosci 27:23–27CrossRefPubMedGoogle Scholar
  28. 28.
    Pandey P, Pradhan S, Modi DR, Mittal B (2009) MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly. Brain Cogn 71:295–299CrossRefPubMedGoogle Scholar
  29. 29.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMedGoogle Scholar
  30. 30.
    Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129CrossRefGoogle Scholar
  31. 31.
    Higgins JP, Thompson SE (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMedGoogle Scholar
  32. 32.
    Whitehead A (2002) Meta-analysis of controlled clinical trials. John Wiley & Sons Ltd, Chichester, West Sussex, EnglandCrossRefGoogle Scholar
  33. 33.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMedGoogle Scholar
  34. 34.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMedGoogle Scholar
  35. 35.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMedGoogle Scholar
  36. 36.
    Egger M, Dave Smith G, Schneider M, Minde C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Bax L, Yu ILM, Tsuruta N, Moons KG (2006) Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 6:50CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Nishiyama M, Kato Y, Hashimoto M, Yukawa S, Omori K (2000) Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia—an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol 10:163–172CrossRefPubMedGoogle Scholar
  39. 39.
    Pollak RD, Pollak A, Idelson M, Bejarano-Achache I, Doron D, Blumenfeld A (2000) The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc 48:664–668CrossRefPubMedGoogle Scholar
  40. 40.
    Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G (2001) Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer’s dementia. A case-control study. Gerontology 47(6):324–329CrossRefPubMedGoogle Scholar
  41. 41.
    McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33:2351–2356CrossRefPubMedGoogle Scholar
  42. 42.
    Wakutani Y, Kowa H, Kusumi M, Yamagata K, Wada-Isoe K, Adachi Y, Takeshima T, Urakam K et al (2002) Genetic analysis of vascular factors in Alzheimer’s disease. Ann N Y Acad Sci 977:232–238CrossRefPubMedGoogle Scholar
  43. 43.
    Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B, Spada R, Caraci F et al (2004) Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer’s disease. Neuroreport 15:859–861CrossRefPubMedGoogle Scholar
  44. 44.
    Bi S, Pan S, Zhang Y, Wu J (2004) Relationship between folate £-vitamin B12 plasma homocysteine levels and polymorphism of MTHFR gene in Alzheimer’s disease. Chin J Mod Med 977:15–18Google Scholar
  45. 45.
    Jiang K, Li F, Zhang M, Qian Y, Wang D, Zhang Y, Jiang S (2004) A study on relationship between the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and Alzheimer disease. Shanghai Arch Psyc 16:196–208Google Scholar
  46. 46.
    Kida T, Kamino K, Yamamoto M, Kanayama D, Tanaka T, Kudo T, Takeda M (2004) C677T polymorphism of methylenetetrahydrofolate reductase gene affects plasma homocysteine level and is a genetic factor of late-onset Alzheimer’s disease. Psychogeriatrics 4:4–10CrossRefGoogle Scholar
  47. 47.
    Liao W, Huang S, Chen S, Wang Y, Liu X (2004) The relationship of polymorphism of MTHFR and plasma homocysteine level with Alzheimer’s disease. Zhong Guo You Sheng Yi Yi Chuan 12:13–15Google Scholar
  48. 48.
    Wang L, Ye L, Wu D, Liu J, Niu J (2004) Genetic risk factors of sporadic Alzheimer’s disease among Chinese in Beijing. Chin J Geriatr 23:460–463Google Scholar
  49. 49.
    Fernandez LL, Scheibe RM (2005) Is MTHFR polymorphism a risk factor for Alzheimer disease like APOE? Arq Neuropsiquiatr 63:1–6CrossRefPubMedGoogle Scholar
  50. 50.
    Zhang YD, Ke XY, Shen W, Liu Y (2005) Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzheimer’s disease. Chin Med Sci J 20:247–251PubMedGoogle Scholar
  51. 51.
    da Silva VC, Ramos FJ, Freitas EM, de Brito-Marques PR, Cavalcanti MN, D’Almeida V, Cabral-Filho JE, Muniz MT (2006) Alzheimer’s disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. Arq Neuropsiquiatr 64:941–945CrossRefPubMedGoogle Scholar
  52. 52.
    Keikhaee MR, Hashemi SB, Najmabadi H, Noroozian M (2006) C677T methylentetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer’s disease in Iranian population. Neurochem Res 31:1079–1083CrossRefPubMedGoogle Scholar
  53. 53.
    Wehr H, Bednarska-Makaruk M, Łojkowska W, Graban A, Hoffman-Zacharska D, Kuczynska-Zardzewiały A, Mrugała J, Rodo M et al (2006) Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement. Geriatr Cogn Disord 22:1–7CrossRefGoogle Scholar
  54. 54.
    Dorszewska J, Florczak J, Rozycka A, Kempisty B, Jaroszewska-Kolecka J, Chojnacka K, Trzeciak WH, Kozubski W (2007) Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer’s and Parkinson’s diseases. Acta Neurobiol Exp (Wars) 67:113–129Google Scholar
  55. 55.
    Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Shin HY, Yoon JS (2008) Methylenetetrahydrofolate reductase gene and risk of Alzheimer’s disease in Koreans. Int J Geriatr Psychiatry 23:454–459CrossRefPubMedGoogle Scholar
  56. 56.
    Yuan Y, Ye Q, Chen Y, Zhang S, Li H, Lu R, Mei G, Li Y et al (2007) Plasma homocysteine level and MTHFR gene polymorphism in old age depression and mild Alzheimer’s disease. Chin J Geriatr 26:767–769Google Scholar
  57. 57.
    Zhang X (2007) Relationship of Hcy and its related enzyme gene polymorphisms with Alzheimer’s disease. Chin Med Sci J 20:1–28Google Scholar
  58. 58.
    Styczynska M, Strosznajder JB, Religa D, Chodakowska-Zebrowska M, Pfeffer A, Gabryelewicz T, Czapsk GA, Kobrys M et al (2008) Association between genetic and environmental factors and the risk of Alzheimer’s disease. Folia Neuropathol 46:249–254PubMedGoogle Scholar
  59. 59.
    Zhang J, Dai Q, Lu W, Meng F (2008) Seruam homocysteine level and MTHFR gene polymorphism and Alzheimer’s disease (AD) risk. Chin J Postgrad Med 31:40–42Google Scholar
  60. 60.
    Bi XH, Zhao HL, Zhang ZX, Zhan JW (2009) Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer’s disease. Neurobiol Aging 30:1601–1607CrossRefPubMedGoogle Scholar
  61. 61.
    Giedraitis V, Kilander L, Degerman-Gunnarsson M, Sundelof J, Axelsson T, Syvanen AC, Lannfelt L, Glaser A (2009) Genetic analysis of Alzheimer’s disease in the Uppsala longitudinal study of adult men. Dement. Geriatr Cogn Disord 27:59–68CrossRefGoogle Scholar
  62. 62.
    Li K, Liu S, Yao S, Wang B, Dai D, Yao L (2009) Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer’s disease risk. Dement. Geriatr Cogn Disord 27:286–291CrossRefGoogle Scholar
  63. 63.
    Ferlazzo N, Gorgone G, Caccamo D, Curro M, Condello S, Pisani F, Ernieri F, Rossini PM et al (2011) The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline. Neuromolecular Med 13:167–174CrossRefPubMedGoogle Scholar
  64. 64.
    Coppede F, Tannorella P, Pezzini I, Migheli F, Ricci G, Caldarazzo lenco E, Piaceri I, Polin A et al (2012) Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer’s disease patients and healthy controls. Antioxid Redox Signal 17:195–204CrossRefPubMedGoogle Scholar
  65. 65.
    Deng X, Wang Y (2012) Association between methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms, Hcy plasma levels and Alzheimer’s disease. Shi Yong Yi Xue 28:3545–3548Google Scholar
  66. 66.
    Mansoori N, Tripathi M, Luthra K, Alam R, Lakshmy R, Sharma S, Arulselvi S, Parveen S et al (2012) MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer’s and vascular dementia and their epistatic interaction. Neurobiol Aging 33(1003):e1001–e1008Google Scholar
  67. 67.
    Divyakolu S, Tejaswini Y, Thomas W, Thumoju S, Sreekanth VR, Vasavi M, OmSai VR, Nagaratna V et al (2013) Evaluation of C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene in various neurological disorders. Neurol Disord 2(1):1000142Google Scholar
  68. 68.
    Elhawary NA, Hewedi D, Arab A, Teama S, Shaibah H, Tayeb MT, Bogari N (2013) The MTHFR 677T allele may influence the severity and biochemical risk factors of Alzheimer’s disease in an Egyptian population. Dis Markers 35:439–446CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Chhillar N, Singh NK, Banerjee BD, Bala K, Basu M, Sharma D (2014) Intergenotypic variation of vitamin B12 and folate in AD: in North Indian population. Ann Indian Acad Neurol 17(3):308–312CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Mansouri L, Fekih-Mrissa N, Klai S, Mansour M, Gritli N, Mrissa R (2013) Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin Neurol Neurosurg 115:1693–1696CrossRefPubMedGoogle Scholar
  71. 71.
    Kronenberg G, Colla M, Endres M (2009) Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 9:315–323CrossRefPubMedGoogle Scholar
  72. 72.
    Yoo JH, Choi GD, Kang SS (2000) Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 20:1921–1925CrossRefPubMedGoogle Scholar
  73. 73.
    Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 29:3–20CrossRefPubMedGoogle Scholar
  74. 74.
    Sachdev PS (2005) Homocysteine and brain atrophy. Pro Neuropsychopharmacology Biol Psychiatry 29:1152–1161CrossRefGoogle Scholar
  75. 75.
    Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J et al (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 22:1752–1762PubMedGoogle Scholar
  76. 76.
    Mattson MP, Shea TB (2003) Folate and homocysteien metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146CrossRefPubMedGoogle Scholar
  77. 77.
    Zhang MY, Miao L, Li YS, Hu GY (2010) Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer’s disease. Neurosci Res 68:142–150CrossRefPubMedGoogle Scholar
  78. 78.
    Hasegawa T, Ukai W, Jo DG, Xu X, Mattson MP, Nakagawa M, Araki W, Saito T et al (2005) Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer’s disease. J Neurosci Res 80:869–876CrossRefPubMedGoogle Scholar
  79. 79.
    Ji C, Kaplowitz N (2004) Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol 10:1699–1708CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S (2006) Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 5:1CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Del Bo R, Angeretti N, Lucca E, De Simoni MG, Forloni G (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett 188:70–74CrossRefPubMedGoogle Scholar
  82. 82.
    Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O, Szuba A, Malinow MR et al (2003) Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylar. Circulation 108:933–938CrossRefPubMedGoogle Scholar
  83. 83.
    Kartal ON, Taha S, Azzi A (2005) Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by interfering with MAPK kinase pathway. Biofactors 24:193–199CrossRefGoogle Scholar
  84. 84.
    Midorikawa S, Sanada H, Hashimoto S, Watanabe T (2000) Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun 272:182–185CrossRefPubMedGoogle Scholar
  85. 85.
    Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20:439–444CrossRefPubMedGoogle Scholar
  86. 86.
    Rai V, Yadav U, Kumar P, Yadav SK, Mishra OP (2014) Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies. PLoS ONE 9:e108552CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Wang W, Wang Y, Gong F, Zhu W, Fu S (2013) MTHFR C677T polymorphism and risk of congenital heart defects: evidence from 29 case-control and TDT studies. PLoS ONE 8:e58041CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Hu CY, Qian ZZ, Gong FF, Lu SS, Feng F, Wu YL, et al. (2014) Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis. J Neural Transm. 2014; [Ahead of print DOI:  10.1007/s00702-014-1261-8].
  89. 89.
    Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L, de Hert M et al (2011) Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun 25:1530–1543CrossRefPubMedGoogle Scholar
  90. 90.
    Wu YL, Ding XX, Sun YH, Yang HY, Chen J, Zhao X, Jiang YH, Lv XL et al (2013) Association between MTHFR C677T polymorphism and depression: an updated meta-analysis of 26 studies. Prog Neuro-Psychopharmacol Biol Psychiatry 46:78–85CrossRefGoogle Scholar
  91. 91.
    Rai V (2014) The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Asian populations. Asian Pac J Cancer Prev 15:5853–5860CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of BiotechnologyHuman Molecular Genetics Laboratory, VBS Purvanchal UniversityJaunpurIndia

Personalised recommendations